Verapamil Approval Analyzed: A Key Update

Zydus Lifesciences has just gotten the green light from the U.S. government to sell Verapamil tablets. These tablets are used to lower high blood pressure. Lowering blood pressure reduces the risk of serious heart issues like strokes and heart attacks.

Key Points

• Zydus gained USFDA approval for Verapamil tablets.
• Tablets treat high blood pressure effectively, consistently.
• Reduced risk of strokes, heart attacks achieved.
• Production in Baddi, Himachal Pradesh, confirmed now.
• Significant market sales: $24.5 million yearly in US.
• Strong existing demand clearly demonstrated by sales.

Background on Verapamil

Verapamil is a medicine that helps relax blood vessels. This makes it easier for the heart to pump blood. It’s a common medicine prescribed for people who have high blood pressure or irregular heartbeats.

Market Impact & Sales

These Verapamil tablets have already been selling well. In the United States, they brought in $24.5 million in sales during the most recent nine months (September 2025, according to IQVIA data). This shows a strong existing market demand for this medication.

Production Location

Zydus Lifesciences will be making these tablets at its facility in Baddi, Himachal Pradesh, India. This ensures a reliable supply of this important medicine.

This approval strengthens Zydus’s position in the hypertension medication market.